A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

NCT01440088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

640

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: TH-302 in Combination with Doxorubicin
DRUG: Doxorubicin

Sponsor

Threshold Pharmaceuticals

Collaborators

[object Object]